Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-11931394-B2
Publication Date
2024-03-19
Expiration Date
Abstract
In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both.
Core Innovation
The invention relates to an herbal supplement comprising a red quebracho extract in an amount between about 0.5% to about 75% by weight of the total supplement and an herbal composition comprising a triterpenoid saponin in an amount between about 10% to about 90% by weight of the total supplement. The supplemental components are presented as herbal extracts intended for oral use in humans.
The problem addressed is the oral treatment of bloating and constipation in humans, including conditions such as irritable bowel syndrome (IBS), functional constipation, chronic abdominal bloating syndrome, and related digestive issues. The description also references undesired weight gain and associated conditions in the context of oral treatment.
The disclosed approach centers on red quebracho extract, including characterization in terms of condensed tannins, and further allows the triterpenoid saponin component to be provided as an herbal composition. Optional adjuncts described include anti-spasmodic herbal extracts such as peppermint oil and additional plant-extract sources for triterpenoid saponin extracts, including Aesculus hippocastanum and Sapindus/Satindus species.
The description characterizes possible mechanisms as protein and/or carbohydrate binding and includes references to reduced methanogenic activity and methane-related effects on motility in a context described as related to digestive conditions. The invention further includes formulation options for oral delivery, including tablets or capsules, nutraceutically acceptable carriers, and enteric coating.
Claims Coverage
The independent claim recites an herbal supplement defined by two main components with quantitative weight ranges: a red quebracho extract and a triterpenoid saponin herbal composition. The claim set includes dependent refinements that add quantitative characterization, specify particular plant-extract sources for the saponin component, and define oral use for reducing bloating in a human subject.
Herbal supplement with red quebracho extract and triterpenoid saponin
An herbal supplement comprising red quebracho extract in an amount between about 0.5% to about 75% by weight of the total supplement and an herbal composition comprising a triterpenoid saponin in an amount between about 10% to about 90% by weight of the total supplement.
Condensed tannins in red quebracho extract
The red quebracho extract contains condensed tannins in an amount between about 50% and about 80%.
Triterpenoid saponin as a plant extract at a defined fraction
The triterpenoid saponin is included as a plant extract in an amount ranging from about 40% to about 65% by weight of the total supplement.
Tablet or capsule with nutraceutically acceptable carrier
The herbal supplement includes a nutraceutically acceptable carrier and is provided as a tablet or capsule.
Oral administration for reducing bloating in a human subject
A method for reducing bloating in a human subject by orally administering an effective amount of the herbal supplement.
Overall, the claims define an herbal supplement by combining quantified red quebracho extract and quantified triterpenoid saponin, with further refinements specifying condensed tannins content, particular plant-extract embodiments for the saponin component, and oral formulation and use for reducing bloating.
Stated Advantages
Treating bloating in humans, including via oral administration of the herbal supplement.
Treating constipation in humans, including within conditions described such as IBS, functional constipation, and chronic abdominal bloating syndrome.
Addressing undesired weight gain in humans, as referenced in the description.
Documented Applications
Oral treatment of bloating in humans by administering an effective amount of the claimed herbal supplement.
Oral treatment of constipation in humans, including conditions referenced as irritable bowel syndrome (IBS) and functional constipation.
Oral treatment within chronic abdominal bloating syndrome as referenced in the description.
Reference to oral treatment related to undesired weight gain in humans (e.g., weight gain/obesity/type II diabetes) as stated in the description.
Interested in licensing this patent?